Skip to main content
Home
FULL MENU Close Menu
Home
Home

Kate Johnson

News

Lebrikizumab monotherapy for AD found safe, effective during induction

Author:
Kate Johnson
Publish date: March 15, 2023

Atopic dermatitis (AD) monotherapy with the lebrikizumab, an interleukin-13 inhibitor, was shown to be both...

  • Read More

News

Causal link found between childhood obesity and adult-onset diabetes

Author:
Kate Johnson
Publish date: March 9, 2023

Bigger children have increased risks for almost all subtypes of adult-onset diabetes, a Mendelian randomization study indicates.

  • Read More

News

Oncologist stars in film and shares philosophy on death

Author:
Kate Johnson
Publish date: February 22, 2023

When a New York oncologist approached the French actress and film director Emmanuelle Bercot in Manhattan, he was thinking big.

  • Read More

News

AD outcomes improved with lebrikizumab and topical steroids

Author:
Kate Johnson
Publish date: January 17, 2023

The percentage of patients who achieved the combined endpoint was more than double for the lebrikizumab plus TCS group vs. the group on TCS alone...

  • Read More

News

Cancer clinics begin to accommodate patients demanding new cancer detection tests

Author:
Kate Johnson
Publish date: January 9, 2023

Sales teams are making a big push for multicancer early detection tests.

  • Read More

News

Cochrane Review bolsters case that emollients don’t prevent AD

Author:
Kate Johnson
Publish date: December 22, 2022

But that message is being diluted by a stream of contradictory conclusions from poor-quality systematic reviews, authors say.

  • Read More

News

A single pediatric CT scan raises brain cancer risk

Author:
Kate Johnson
Publish date: December 12, 2022

"CT examinations should only be used when necessary, and if they are used, the lowest achievable dose should be applied."

  • Read More

News

Study comparing surgical and N95 masks sparks concern

Author:
Kate Johnson
Publish date: December 6, 2022

The findings are not consistent with those of many other studies on this topic.

  • Read More

News

Will a one-dose drug mean the end of sleeping sickness?

Author:
Kate Johnson
Publish date: November 30, 2022

The drug has “the potential to revolutionize treatment” for the disease.

  • Read More

News

Study affirms shorter regimens for drug-resistant tuberculosis

Author:
Kate Johnson
Publish date: November 29, 2022

The findings validate the World Health Organization’s current recommendation.

  • Read More

News

New genetic variant linked to maturity-onset diabetes of the young

Author:
Kate Johnson
Publish date: November 29, 2022

The reported variant in Greenlandic Inuit individuals has the largest population impact of any previously reported variant within a MODY gene.

  • Read More

News

Study finds chronic jet lag–like body clocks in people with HIV

Author:
Kate Johnson
Publish date: November 28, 2022

The mistimed circadian phase in people living with HIV is linked to later sleep onset and earlier waking and has “important potential implications...

  • Read More

News

New statement guides the diagnosis of pediatric anxiety

Author:
Kate Johnson
Publish date: November 2, 2022

Clinicians must distinguish between normal anxiety, situational anxiety, and specific anxiety disorder. “It’s detective work.”

  • Read More

News

Rapid action or sustained effect? Methotrexate vs. ciclosporin for pediatric AD

Author:
Kate Johnson
Publish date: November 2, 2022

In the TREAT trial, 103 patients with AD (mean age, 10 years) who had not responded to topical treatment, were randomly assigned to oral...

  • Read More

News

Online support tool improves AD self-management

Author:
Kate Johnson
Publish date: November 2, 2022

The intervention, directed either at parents of children with AD or young adults with AD, “is very low cost, evidence based, easily accessible,...

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close